Components

Activities

National Drugs Observatories

  • 1.1 - Mapping the situation on NDOs: Follow-up/Baseline study

    Go to activity
  • 1.2 - Identification of groups of countries according to the development stage of their NDO.

    Go to activity
  • 1.3 - South-South Cooperation: promotion and facilitation of the establishment of national Early Warning Systems (EWS) in CELAC countries

    Go to activity
    • 1.3.1 - 1st Meeting of the Working Group (WG) Early Warning System

      Go to activity
    • 1.3.2 - 2nd Meeting of the Working Group (WG) Early Warning System

      Go to activity
    • 1.3.3 - 3rd Meeting of the Working Group (WG) Early Warning System

      Go to activity
  • 1.4 - Studies to evaluate and validate scales and indicators of “Problematic Drug Use" (PDU)

    Go to activity
    • 1.4.1 - 1st Meeting Working Group (WG) Design of studies to evaluate and validate scales and indicators of “Problematic Drug Use”

      Go to activity
    • 1.4.2 - 2nd Meeting Working Group (WG) Design of studies to evaluate and validate scales and indicators of “Problematic Drug Use”

      Go to activity
  • 1.5 - Capacity-building for the elaboration of first country reports

    Go to activity
    • 1.5.1.en - 1st Meeting of the Coordination and Advisory Levels of Working Group (WG) Enhancing the capacity of NDOs, to elaborate and disseminate a Country Report on drugs (English Speakers)

      Go to activity
    • 1.5.1.es - 1st Meeting of the Coordination and Advisory Levels of Working group (WG) Enhancing the capacity of NDOs, to elaborate and disseminate a Country Report on drugs (Spanish speakers)

      Go to activity
    • 1.5.2 - 2nd Meeting of the Coordination and Advisory Levels of Working group (WG) Enhancing the capacity of NDOs, to elaborate and disseminate a Country Report on drugs

      Go to activity
    • 1.5.3 - 3rd Meeting of the Coordination and Advisory Levels of WG 1.5 Enhancing the capacity of NDOs, to elaborate and disseminate a Country Report on drugs

      Go to activity
  • 1.6 - Capacity-building on problematic use and new threats

    Go to activity
    • 1.6.1 - 1st Advisory Level Meeting Working Group (WG) Developing Methodologies for a better understanding of new problems or threats

      Go to activity
    • 1.6.2 - 2nd Advisory Level Meeting Working Group (WG) Developing Methodologies for a better understanding of new problems or threats

      Go to activity
  • 1.7 - On-line capacity-building: Operational implications of adopting the Public Health model

    Go to activity
  • 1.8 - Annual meeting of NDOs

    Go to activity
    • 1.8.1 - 1st COPOLAD II Annual Meeting National Drugs Observatories

      Go to activity
    • 1.8.2 - 2nd COPOLAD II Annual Meeting National Drugs Observatories

      Go to activity

Drugs Demand Reduction

  • 2.1 - Validation of quality and evidence-based criteria agreed during C1 in the field of DDR

    Go to activity
    • 2.1.1 - Validation of quality and evidence-based criteria in Latin America

      Go to activity
      • 2.1.1.1 - Validation of the basic quality and evidence-based criteria for treatment programmes
        Go to activity
      • 2.1.1.1./2/3 - 2nd Meeting for the validation of basic and advanced quality and evidence-based criteria for treatment and prevention programmes
        Go to activity
      • 2.1.1.1.1-R1 - 1st meeting for the validation of basic quality and evidence-based criteria for treatment programmes
        Go to activity
      • 2.1.1.2 - Validation of advanced quality and evidence-based criteria for treatment and harm reduction programmes
        Go to activity
      • 2.1.1.2.1-R1 - 1st meeting for the validation of quality and evidence-based advanced criteria for treatment and harm reduction programmes
        Go to activity
      • 2.1.1.3 - Validation of quality and evidence-based criteria for prevention programmes
        Go to activity
      • 2.1.1.3.1-R1 - 1st meeting Validation of quality and evidence-based criteria for prevention programmes
        Go to activity
    • 2.1.2 - Adaptation and validation of quality and evidence-based criteria in Caribbean countries

      Go to activity
      • 2.1.2.1-R1 - 1st meeting Adaptation and validation of quality and evidence-based criteria in Caribbean countries
        Go to activity
      • 2.1.2.2-R2 - 2nd Meeting Adaptation and validation of quality and evidence-based criteria in Caribbean countries
        Go to activity
  • 2.3 - Exchange of best practices in key areas of DDR: bi-regional meetings to identify and exchange best and innovative practices to face emerging challenges

    Go to activity
    • 2.3.1 - 1st Bi-regional meeting to enhance the exchange of best practices: Drugs Policy and criminal justice reform: alternative treatment to prison for drug offences

      Go to activity
  • 2.4 - Directory of Centers and Services in DDR

    Go to activity
  • 2.5 - Further expansion of the capacity-building strategy in DDR

    Go to activity
    • 2.5.1 - The use of alcohol and other drugs: Evidence-based prevention

      Go to activity
      • 2.5.1.es - International Edition (Spanish version): The use Alcohol and other drugs: Evidence-based prevention
        Go to activity
      • 2.5.1.po - International Edition (Portuguese) The use of alcohol and other drugs: Evidence-based prevention
        Go to activity
    • 2.5.2 - Comprehensive and Integrated Drug Related Socio-Sanitary System at the Primary Care

      Go to activity
      • 2.5.2.es - International Edition (Spanish version): Comprehensive and Integrated Socio-Sanitary Care System in Drug Dependence at the Primary Care level
        Go to activity
      • 2.5.2.po - International Edition (Portuguese version): Comprehensive and Integrated Socio-Sanitary Care System in Drug Dependence at the Primary Care level
        Go to activity
    • 2.5.3 - Public Health approach to drugs policies

      Go to activity
      • 2.5.3.es - International edition (Spanish/Portuguese version): Public Health approach to drugs policies
        Go to activity
    • 2.5.4 - Comprehensive approach to the prevention and reduction of the adverse consequences of drug use in populations in situation of high vulnerability: a public health strategy

      Go to activity
    • 2.5.5 - National Editions of the Online Courses in CELAC countries

      Go to activity
  • 2.6 - Promotion and implementation of support resources for planning and evaluating DDR programmes

    Go to activity
    • 2.6.1 - Bank of evaluation tools for DDR programmes

      Go to activity
    • 2.6.2 - Planning & evaluation platform Paso@Paso (One Step@a Time)

      Go to activity
    • 2.6.3 - Capacity building to facilitate the use of the planning programme Paso@Paso (One Step@a Time)

      Go to activity

Drugs Supply Reduction

  • 3.1 - Facilitating intra-regional exchange of best practices and peer-to-peer learning in the field of alternative development (AD)

    Go to activity
    • 3.1.1 - Intra-regional Dialogue Forums on Alternative Development

      Go to activity
      • 3.1.1.1 - 1st Intra-regional dialogue forum in Alternative Development
        Go to activity
      • 3.1.1.2 - 2nd Intra-regional dialogue forum in Alternative Development
        Go to activity
      • 3.1.1.3 - 3rd Intra-regional dialogue Forum on Alternative Development
        Go to activity
    • 3.1.2 - Peer-to-peer learning activities in AD

      Go to activity
      • 3.1.2.1 - 1st Peer-to-peer workshop: Alternative development and value chains
        Go to activity
      • 3.1.2.2 - 2nd Peer-to-peer workshop: Alternative development and value chains
        Go to activity
      • 3.1.2.3 - 3rd Peer-to-peer workshop: Alternative development and value chains
        Go to activity
  • 3.3 - Improving evidence in the field of AD

    Go to activity
    • 3.3.1 - Study on successful factors strengthening the institutional capacities in Alternative Development. Case Study: Guatemala, Paraguay and Peru

      Go to activity
  • 3.4 - Capacity building and exchange of best practices in Law Enforcement

    Go to activity
    • 3.4.1 - 1st Bi-regional meeting to enhance the exchange of best practices: Drugs Policy and criminal justice reform: alternative treatment to prison for drug related crimes

      Go to activity
    • 3.4.2 - 4th Bi-Regional Meeting EU-CELAC for the Exchange of Best Practices: Cross-cutting seminar in the field of Money laundering

      Go to activity
    • 3.4.3 - 2nd Bi-Regional Meeting EU-CELAC for the Exchange of Best Practices: Effective mechanisms to counteract cocaine Illicit drug trafficking routes

      Go to activity
  • 3.5 - Sustainable capacity building and exchange of best practices in the field of prevention and control of chemical precursors' diversion for the production of illicit drugs

    Go to activity
    • 3.5.1 - Promotion of best practices/information sharing

      Go to activity
      • 3.5.1.1 - 1st Annual Week on Precursors: Importance of the collaboration for the exchange and gathering of information between the public and private sectors
        Go to activity
      • 3.5.1.2 - 2nd Annual Week on Precursors
        Go to activity
      • 3.5.1.3 - 3rd Annual Week on Precursors
        Go to activity
    • 3.5.2 - Working groups in Precursors Control

      Go to activity
      • 3.5.2.1 - Working Group 1. Adaptation and translation of protocols and guidelines for precursors control
        Go to activity
      • 3.5.2.1.2 - 2nd COPOLAD II Working Group 1 meeting on Precursors
        Go to activity
      • 3.5.2.2 - Working Group 2. Impulse to legislation for precursors control
        Go to activity
      • 3.5.2.2.1 - 1st COPOLAD II Working Group 2 meeting on Precursors
        Go to activity
      • 3.5.2.2.2 - 2nd COPOLAD II Working Group 2 meeting on Precursors
        Go to activity

Dialogue & Mechanism

  • 4.1 - Organization of COPOLAD's Annual Conferences

    Go to activity
    • 4.1.1 - 1st COPOLAD II Annual Conference: From evidence to practice: challenges in the field of drugs policies

      Go to activity
    • 4.1.2 - 2nd COPOLAD II Annual Conference: Use of the Internet for the illicit sale of drugs and new psychoactive substances: challenges for their approach through coordinated and effective policies

      Go to activity
    • 4.1.3 - 3rd COPOLAD II Annual Conference: Women and drugs policy

      Go to activity
    • 4.1.3-pc - 3rd Annual Meeting of the Permanent Council of COPOLAD

      Go to activity
  • 4.2 - Promotion and enlargement of the Mechanism's E-room at the COPOLAD website

    Go to activity
  • 4.3 - Provision of technical inputs from COPOLAD relevant for policy-making

    Go to activity
    • 4.3.1 - Technical report: Gender and empowerment of women in drug policies

      Go to activity

Crosscutting issues

  • 0.10 - Visibility Strategy

    Go to activity
    • 0.10.3 - Programme presentation at national, regional, bi-regional or international events

      Go to activity
      • 0.10.3.1 - Side event at the 59th CND 2016. Towards an improved response to drugs challenges
        Go to activity
      • 0.10.3.2 - Side event UNGASS 2016
        Go to activity
      • 0.10.3.3 - COPOLAD presentation at Info Point
        Go to activity
      • 0.10.3.4 - COPOLAD presentation at EMCDDA
        Go to activity
      • 0.10.3.5 - COPOLAD presentation at CICAD
        Go to activity
      • 0.10.3.6 - First Regional Meeting on New Psychoactive Substances (NPS) in the Western Hemisphere (Americas)
        Go to activity
      • 0.10.3.7 - Dialogues about the implementation of the recommendations of UNGASS 2016
        Go to activity
      • 0.10.3.8 - XVII Meeting of the group of experts on Demand Reduction (CICAD-OAS)
        Go to activity
      • 0.10.3.9 - Side Event of COPOLAD at the 60th CND 2017: Building support tools for evidence-based policy-making on drugs
        Go to activity
      • 0.10.3.10 - XVIII Meeting of the group of experts on Demand Reduction (CICAD-OAS)
        Go to activity
      • 0.10.3.11 - 2nd European Conference on Addictive Behaviours and Dependencies, Lisbon Addictions
        Go to activity
      • 0.10.3.12 - EU-CELAC second seminar on Citizen Security. Implementation of Chapter 10 of the EU-CELAC Action Plan
        Go to activity
      • 0.10.3.13 - Meeting of the Directors of National Drug Councils to review, revise & update the Regional Drug Demand Reduction Strategy
        Go to activity
      • 0.10.3.14 - Side Event COPOLAD at 61st CND 2018. South-South cooperation supported by the European Union: aims, actors,activities and outcomes
        Go to activity
      • 0.10.3.15 - Presentation of COPOLAD at XX RIOD Seminary
        Go to activity
      • 0.10.3.16 - 2nd Regional Meeting on New Psychoactive Substances (NPS) in the Western Hemisphere (Americas)
        Go to activity
      • 0.10.3.17 - Presentation of COPOLAD in PREDEM
        Go to activity
      • 0.10.3.18 - II Forum on Policies and Programmes for the Preventive Intervention in the Educative field
        Go to activity
      • 0.10.3.19 - XIX Meeting of the group of experts on Demand Reduction (CICAD-OAS)
        Go to activity
      • 0.10.3.20 - Workshop to Strengthen National Drug Observatories in Latin America
        Go to activity
      • 0.10.3.21 - 3rd CICAD / OAS Experts Meeting in Comprehensive and Sustainable Alternative Development
        Go to activity
      • 0.10.3.22 - Executive Training Pompidou Group. Drugs Policies Evaluation and the development of new indicators for measuring its effectiveness
        Go to activity
  • 0.8-9 - Institutional Coordination meetings and contacts.

    Go to activity
    • 0.8-9.17 - Experts meeting on Drugs: EU Policy cycle 2018-2021 and Cooperation programmes on Drugs policies

      Go to activity
    • 0.8-9.20 - Interagency meeting on standards of care for problematic drug users in the Americas

      Go to activity